Responses
Regular and young investigator award abstracts
Biomarkers, immune monitoring, and novel technologies
38 Clinical validation of an image analysis assay for determining programmed death-ligand 1 (22C3) in non-small cell lung cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
